Blnk/Hdac9 maintains the nuclear localization of Foxo1 through supressing BCR-ABL1 kinase activity in BCR-ABL1+ B-cell acute lymphoblastic leukemia

被引：0
|
作者：
Zhang, P. [1 ]
Yu, X. [1 ]
Yuan, M. [1 ]
Wang, Y. [1 ]
Ji, Y. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P0672
引用
收藏
页码：324 / 324
页数：1
相关论文
共 50 条
  • [1] BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?
    Takahashi, Taro
    Ichikawa, Satoshi
    Ichinohasama, Ryo
    Harigae, Hideo
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1265 - 1267
  • [2] SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia
    Brown, Lauren M.
    Hediyeh-Zadeh, Soroor
    Sadras, Teresa
    Huckstep, Hannah
    Sandow, Jarrod J.
    Bartolo, Ray C.
    Kosasih, Hansen J.
    Davidson, Nadia M.
    Schmidt, Breon
    Bjelosevic, Stefan
    Johnstone, Ricky
    Webb, Andrew, I
    Khaw, Seong L.
    Oshlack, Alicia
    Davis, Melissa J.
    Ekert, Paul G.
    BLOOD ADVANCES, 2022, 6 (07) : 2373 - 2387
  • [3] In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
    Buzzatti, Elisa
    Forghieri, Fabio
    Paterno, Giovangiacinto
    Marchesi, Francesco
    Sarlo, Chiara
    Giglio, Fabio
    Fracchiolla, Nicola
    Sciume, Mariarita
    Palmieri, Raffaele
    Esposito, Fabiana
    Guarnera, Luca
    Mercante, Lisa
    Pascale, Maria Rosaria
    Mallegni, Flavia
    Savi, Arianna
    Forte, Vittorio
    Maurillo, Luca
    Buccisano, Francesco
    Venditti, Adriano
    Del Principe, Maria Ilaria
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [4] T-Cell acute lymphoblastic leukemia with a pinch of BCR-ABL1
    Cortes, Jorge
    De Keersmaecker, Kim
    LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 321 - 322
  • [5] γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia
    Luong-Gardiol, Noemie
    Siddiqui, Imran
    Pizzitola, Irene
    Jeevan-Raj, Beena
    Charmoy, Melanie
    Huang, Yun
    Irmisch, Anja
    Curtet, Sara
    Angelov, Georgi S.
    Danilo, Maxime
    Juilland, Melanie
    Bornhauser, Beat
    Thome, Margot
    Hantschel, Oliver
    Chalandon, Yves
    Cazzaniga, Gianni
    Bourquin, Jean-Pierre
    Huelsken, Joerg
    Held, Werner
    CANCER CELL, 2019, 35 (04) : 649 - +
  • [6] Combination of BCR-ABL1 Tyrosine Kinase Inhibitors with a Small Molecule LIM kinase1/2 Inhibitor in BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
    Braun, Thorsten
    Berrou, Jeannig
    Prudent, Renaud
    Djamai, Hanane
    Dupont, Melanie
    Kaci, Anna
    Adiceam, Emilie
    Paublant, Fabrice
    Baruchel, Andre
    Ghysdael, Jacques
    Gardin, Claude
    Dombret, Herve
    BLOOD, 2018, 132
  • [7] Reversibility of acute B-cell leukaemia induced by BCR-ABL1
    Huettner, CS
    Zhang, P
    Van Etten, RA
    Tenen, DG
    NATURE GENETICS, 2000, 24 (01) : 57 - 60
  • [8] ABL1 Gene Deletion without BCR/ABL1 Rearrangement in B-Cell Acute Lymphoblastic Leukemia
    Yu, Mingwei
    Chang, Jason
    Gao, Wenli
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 : S6 - S7
  • [9] Retrospective analysis of toxicities and clinical outcomes with BCR-ABL1 tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia.
    Venn, Chad Michael
    Zacholski, Kyle
    Tran, Valerie
    Alnimer, Yanal Mufeed
    Ho, Thuy
    Maher, Keri Renee
    Bouligny, Ian Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia
    Kaumeyer, Benjamin
    Fidai, Shiraz
    Sukhanova, Madina
    Yap, Kai Lee
    Segal, Jeremy
    Raca, Gordana
    Stock, Wendy
    McNeer, Jennifer
    Lager, Angela M.
    Gurbuxani, Sandeep
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1436 - 1444
12345